Fiche du document
- doi: 10.1007/s00296-018-3951-2
- issn: 0172-8172
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00296-018-3951-2
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/29637356
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1437-160X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_26F56E1934D48
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Joints--Inflammation ArthritidesCiter ce document
P. Quartier et al., « The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). », Serveur académique Lausannois, ID : 10.1007/s00296-018-3951-2
Métriques
Partage / Export
Résumé
The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the French language. The reading comprehension of the questionnaire was tested in 10 JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach's alpha, interscale correlations and construct validity (convergent and discriminant validity). A total of 100 JIA patients (23% systemic, 45% oligoarticular, 20% RF negative polyarthritis, 12% other categories) and 122 healthy children, were enrolled at the paediatric rheumatology centre of the Necker Children's Hospital in Paris. Notably, none of the enrolled JIA patients is affected with psoriatic arthritis. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the French version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.